BlackRock Health Sciences Term Trust (NYSE:BMEZ – Get Free Report) was the recipient of a large decline in short interest in the month of July. As of July 31st, there was short interest totaling 60,925 shares, a decline of 42.0% from the July 15th total of 105,031 shares. Based on an average daily volume of 120,769 shares, the short-interest ratio is presently 0.5 days.
Institutional Trading of BlackRock Health Sciences Term Trust
A number of large investors have recently made changes to their positions in the stock. CWM LLC boosted its position in BlackRock Health Sciences Term Trust by 25.6% in the 4th quarter. CWM LLC now owns 3,336 shares of the company’s stock worth $50,000 after purchasing an additional 680 shares in the last quarter. Steward Partners Investment Advisory LLC grew its position in BlackRock Health Sciences Term Trust by 4.9% during the fourth quarter. Steward Partners Investment Advisory LLC now owns 14,687 shares of the company’s stock valued at $221,000 after buying an additional 688 shares during the period. Private Advisor Group LLC raised its position in shares of BlackRock Health Sciences Term Trust by 3.5% in the third quarter. Private Advisor Group LLC now owns 28,039 shares of the company’s stock worth $404,000 after acquiring an additional 940 shares during the period. PMG Family Office LLC grew its position in shares of BlackRock Health Sciences Term Trust by 4.9% during the 1st quarter. PMG Family Office LLC now owns 28,227 shares of the company’s stock valued at $405,000 after acquiring an additional 1,320 shares during the period. Finally, Kestra Advisory Services LLC purchased a new position in shares of BlackRock Health Sciences Term Trust in the 4th quarter valued at about $26,000.
BlackRock Health Sciences Term Trust Stock Performance
Shares of NYSE:BMEZ opened at $16.05 on Monday. The business has a 50 day simple moving average of $15.27 and a two-hundred day simple moving average of $14.76. BlackRock Health Sciences Term Trust has a 1 year low of $13.70 and a 1 year high of $16.25.
BlackRock Health Sciences Term Trust Dividend Announcement
BlackRock Health Sciences Term Trust Company Profile
BlackRock Health Sciences Term Trust (NYSE: BMEZ) is a closed-end management investment company organized as a Delaware statutory trust. Launched in March 2020, BMEZ seeks to provide total return through a combination of current income and capital appreciation by investing primarily in equity and equity-related securities of companies in the health sciences sector. The trust is structured with a fixed termination date in October 2030, at which time shareholders will vote on its liquidation, extension or conversion.
The fund’s investment portfolio is diversified across subsectors within health sciences, including biotechnology, pharmaceuticals, medical devices, diagnostics and healthcare services.
Further Reading
- Five stocks we like better than BlackRock Health Sciences Term Trust
- 3 ETFs Built to Protect Your Money if the Bull Market Breaks
- JFrog’s AI Opportunity Could Fuel a Big Leap in Share Price
- Is SiTime the Best AI Stock You’ve Never Heard Of?
- The Metals Company’s Big Bet Now Comes Down to a License
Receive News & Ratings for BlackRock Health Sciences Term Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BlackRock Health Sciences Term Trust and related companies with MarketBeat.com's FREE daily email newsletter.
